Assoc. Prof. Dr. Xinkuan Cheng, Tianjin university of science and technology, China
Assoc. Prof. Dr. Xinkuan Cheng is a distinguished researcher in bioengineering at the School of Bioengineering, Tianjin University of Science and Technology. He earned his Ph.D. from the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences in 2019 🎓. His research focuses on CRISPR/Cas-based biosensors and synthetic biology, with highly cited publications in Biosensors & Bioelectronics and the Chemical Engineering Journal 📚. With over 123 citations and an editorial role at Sensors & Diagnostics 📝, Dr. Cheng is recognized for his innovative contributions to biotechnology and molecular diagnostics
Publication Profile
Scopus
Orcid
🎓 Education
Assoc. Prof. Dr. Xinkuan Cheng earned his Ph.D. in 2019 from the prestigious Tianjin Institute of Industrial Biotechnology, part of the Chinese Academy of Sciences. During his doctoral studies, he delved into advanced biotechnological research, honing expertise in fields like synthetic biology, metabolic engineering, and enzyme technology. His rigorous training equipped him with strong analytical and experimental skills, enabling him to tackle complex scientific challenges. This foundational education has been pivotal in shaping his innovative research trajectory in bioengineering and molecular diagnostics, setting a solid academic and professional cornerstone for his continued contributions to science.
🏅 Professional Recognition
Assoc. Prof. Dr. Xinkuan Cheng has earned notable professional recognition for his expertise in the field of bioengineering. Since 2024, he has served on the Editorial Board of Sensors & Diagnostics, a respected scientific journal that highlights innovations in sensing technologies and diagnostic tools. 📘 His editorial role reflects his scholarly influence, peer recognition, and dedication to advancing high-quality research. 🌐 This position not only demonstrates his leadership in evaluating cutting-edge studies but also showcases his commitment to academic excellence and mentorship in the global scientific community. 🧬 His contributions continue to shape emerging trends in biosensors and diagnostics
🧪 Research Focus
Assoc. Prof. Dr. Xinkuan Cheng’s research centers on enzyme engineering, synthetic biology, and CRISPR-based diagnostics 🧬. He develops novel enzymatic pathways for the biosynthesis of fluorinated compounds and coenzymes like SAM 🧫, and engineers enzymes with enhanced specificity and stereoselectivity ⚙️. His work also explores CRISPR/Cas systems for the rapid detection of pathogens like HR-HPV 🧻, pushing the frontiers of molecular diagnostics 🔍. With publications in top journals such as Biosensors & Bioelectronics, Microbiology Spectrum, and Drug Discovery Today, his multidisciplinary research impacts biocatalysis, healthcare, and industrial biotechnology
Publication Top Notes
📄 Development and evaluation of a CRISPR/Cas12a-based diagnostic test for rapid detection and genotyping of HR-HPV in clinical specimens – Microbiology Spectrum, 2025, DOI: 10.1128/spectrum.02253-24,
📄 Novel non-nucleic acid targets detection strategies based on CRISPR/Cas toolboxes: A review – Biosensors & Bioelectronics, 2022, DOI: 10.1016/j.bios.2022.114559,
📄 Enzymatic synthesis of fluorinated compounds – Applied Microbiology and Biotechnology, 2021, DOI: 10.1007/s00253-021-11608-0,
📄 Identification of methionine adenosyltransferase with high diastereoselectivity… – Enzyme and Microbial Technology, 2021, DOI: 10.1016/j.enzmictec.2021.109881,
📄 Potential and promising anticancer drugs from adenosine and its analogs – Drug Discovery Today, 2021, DOI: 10.1016/j.drudis.2021.02.020,
📄 Structure-guided engineering of meso-diaminopimelate dehydrogenase… – Catalysis Science & Technology, 2018, DOI: 10.1039/c8cy01426d,
📄 Highly Atom Economic Synthesis of D-2-Aminobutyric Acid through an in vitro tri-enzymatic catalytic system – ChemistryOpen, 2017, DOI: 10.1002/open.201700093,